Modulight Biotherapeutics

Modulight Biotherapeutics is pioneering a new era of medicine for patients with neurological disorders — an era defined by speed, precision, and the promise of true relief without side effects. The company’s platform uses a unique approach to modulate neuronal activity, employing light-activated proteins specifically targeting pathological cells and neural pathways. Modulight's therapeutic platform is based on technology licensed from YEDA, the commercial arm of the Weizmann Institute of Science.